Literature DB >> 9177925

Autoantibodies to collagens in Japanese patients with ankylosing spondylitis.

Y Tani1, H Sato, S Hukuda.   

Abstract

OBJECTIVE: We measured antibody levels against human type I, II, III and IV collagens in Japanese patients with ankylosing spondylitis (AS) by enzyme linked immunosorbent assay (ELISA).
RESULTS: Significant elevations of antibodies against type II (IgG and IgA classes) and type IV (IgA class) collagens were observed in AS patients, whilst there was no significant elevation of any antibody class against type I or III collagen when compared to controls.
CONCLUSION: These findings indicate that AS patients have immune responses to type II and IV collagens, which may be responsible for sustaining the characteristic local inflammations in AS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177925

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.

Authors:  Cynthia Wright; Sahar Sibani; David Trudgian; Roman Fischer; Benedikt Kessler; Joshua LaBaer; Paul Bowness
Journal:  Mol Cell Proteomics       Date:  2012-02       Impact factor: 5.911

2.  Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.

Authors:  Yong-Gil Kim; Dong Hyun Sohn; Xiaoyan Zhao; Jeremy Sokolove; Tamsin M Lindstrom; Bin Yoo; Chang-Keun Lee; John D Reveille; Joel D Taurog; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

Review 3.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

4.  Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis.

Authors:  Rik J U Lories; Inge Derese; Frank P Luyten
Journal:  J Clin Invest       Date:  2005-05-12       Impact factor: 14.808

5.  Antibodies Directed against a Peptide Epitope of a Klebsiella pneumoniae-Derived Protein Are Present in Ankylosing Spondylitis.

Authors:  Antonio Puccetti; Marzia Dolcino; Elisa Tinazzi; Francesca Moretta; Salvatore D'Angelo; Ignazio Olivieri; Claudio Lunardi
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

6.  Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker.

Authors:  Qiongyi Hu; Yue Sun; Yuan Li; Hui Shi; Jialin Teng; Honglei Liu; Xiaobing Cheng; Junna Ye; Yutong Su; Yufeng Yin; Mengru Liu; Jiucun Wang; Chengde Yang
Journal:  BMC Immunol       Date:  2018-12-17       Impact factor: 3.615

7.  A Potential New Mouse Model of Axial Spondyloarthritis Involving the Complement System.

Authors:  V Michael Holers; Francisco G La Rosa; Nirmal K Banda
Journal:  Immune Netw       Date:  2021-12-15       Impact factor: 6.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.